Managing the challenge of drug-induced liver injury a roadmap for the development and deployment of preclinical predictive models - Université de Rennes Access content directly
Journal Articles Nature Reviews Drug Discovery Year : 2020

Managing the challenge of drug-induced liver injury a roadmap for the development and deployment of preclinical predictive models

Abstract

Drug-induced liver injury (DILI) is a patient-specific, temporal, multifactorial pathophysiological process that cannot yet be recapitulated in a single in vitro model. Current preclinical testing regimes for the detection of human DILI thus remain inadequate. A systematic and concerted research effort is required to address the deficiencies in current models and to present a defined approach towards the development of new or adapted model systems for DILI prediction. This Perspective defines the current status of available models and the mechanistic understanding of DILI, and proposes our vision of a roadmap for the development of predictive preclinical models of human DILI.
Fichier principal
Vignette du fichier
Weaver et al-2020-Managing the challenge of drug-induced liver injury.pdf (2.29 Mo) Télécharger le fichier
Weaver_41573_2019_48_MOESM1_ESM.pdf (1.26 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-02397617 , version 1 (16-06-2021)

Identifiers

Cite

Christopher E Goldring, André Guillouzo, Philip G Hewitt, Magnus Ingelman-Sundberg, Klaus Gjervig Jensen, et al.. Managing the challenge of drug-induced liver injury a roadmap for the development and deployment of preclinical predictive models. Nature Reviews Drug Discovery, 2020, 19 (2), pp.131-148. ⟨10.1038/s41573-019-0048-x⟩. ⟨hal-02397617⟩
910 View
1320 Download

Altmetric

Share

Gmail Facebook X LinkedIn More